633 related articles for article (PubMed ID: 26026171)
21. Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.
Chowdhary A; Sharma C; Hagen F; Meis JF
Future Microbiol; 2014; 9(5):697-711. PubMed ID: 24957095
[TBL] [Abstract][Full Text] [Related]
22. Isolation of azole-resistant Aspergillus fumigatus from the environment in the south-eastern USA.
Hurst SF; Berkow EL; Stevenson KL; Litvintseva AP; Lockhart SR
J Antimicrob Chemother; 2017 Sep; 72(9):2443-2446. PubMed ID: 28575384
[TBL] [Abstract][Full Text] [Related]
23. High prevalence of triazole resistance in clinical Aspergillus fumigatus isolates in a specialist cardiothoracic centre.
Abdolrasouli A; Scourfield A; Rhodes J; Shah A; Elborn JS; Fisher MC; Schelenz S; Armstrong-James D
Int J Antimicrob Agents; 2018 Nov; 52(5):637-642. PubMed ID: 30103005
[TBL] [Abstract][Full Text] [Related]
24. In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.
Arendrup MC; Jensen RH; Cuenca-Estrella M
Antimicrob Agents Chemother; 2016 Jan; 60(1):532-6. PubMed ID: 26552973
[TBL] [Abstract][Full Text] [Related]
25. Contributions of both ATP-Binding Cassette Transporter and Cyp51A Proteins Are Essential for Azole Resistance in Aspergillus fumigatus.
Paul S; Diekema D; Moye-Rowley WS
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264842
[TBL] [Abstract][Full Text] [Related]
26. High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance.
Takeda K; Suzuki J; Watanabe A; Arai T; Koiwa T; Shinfuku K; Narumoto O; Kawashima M; Fukami T; Tamura A; Nagai H; Matsui H; Kamei K
Med Mycol; 2021 Apr; 59(4):327-334. PubMed ID: 32642756
[TBL] [Abstract][Full Text] [Related]
27. Azole resistance in Aspergillus isolates by different types of patients and correlation with environment - An Italian prospective multicentre study (ARiA study).
Prigitano A; Esposto MC; Grancini A; Biffi A; Innocenti P; Cavanna C; Lallitto F; Mollaschi EMG; Bandettini R; Oltolini C; Passera M; De Lorenzis G; Sargolzaei M; Crespan M; Cogliati M; Tortorano AM; Romanò L
Mycoses; 2021 May; 64(5):528-536. PubMed ID: 33438319
[TBL] [Abstract][Full Text] [Related]
28. Determination of Azole Resistance and TR
Güngör Ö; Sampaio-Maia B; Amorim A; Araujo R; Erturan Z
Mycopathologia; 2018 Dec; 183(6):913-920. PubMed ID: 30187246
[TBL] [Abstract][Full Text] [Related]
29. Azole resistance among clinical isolates of Aspergillus fumigatus in Lima-Peru.
Bustamante B; Illescas LR; Posadas A; Campos PE
Med Mycol; 2020 Jan; 58(1):54-60. PubMed ID: 31329931
[TBL] [Abstract][Full Text] [Related]
30. Azole resistance in canine and feline isolates of Aspergillus fumigatus.
Talbot JJ; Kidd SE; Martin P; Beatty JA; Barrs VR
Comp Immunol Microbiol Infect Dis; 2015 Oct; 42():37-41. PubMed ID: 26387063
[TBL] [Abstract][Full Text] [Related]
31. Azole-resistant Aspergillus fumigatus isolates carrying TR₃₄/L98H mutations in Taiwan.
Wu CJ; Wang HC; Lee JC; Lo HJ; Dai CT; Chou PH; Ko WC; Chen YC
Mycoses; 2015 Sep; 58(9):544-9. PubMed ID: 26214171
[TBL] [Abstract][Full Text] [Related]
32. Single-Center Evaluation of an Agar-Based Screening for Azole Resistance in Aspergillus fumigatus by Using VIPcheck.
Buil JB; van der Lee HAL; Rijs AJMM; Zoll J; Hovestadt JAMF; Melchers WJG; Verweij PE
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923874
[TBL] [Abstract][Full Text] [Related]
33. High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue?
Nabili M; Shokohi T; Moazeni M; Khodavaisy S; Aliyali M; Badiee P; Zarrinfar H; Hagen F; Badali H
J Med Microbiol; 2016 Jun; 65(6):468-475. PubMed ID: 27008655
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
Buil JB; Rijs AJMM; Meis JF; Birch M; Law D; Melchers WJG; Verweij PE
J Antimicrob Chemother; 2017 Sep; 72(9):2548-2552. PubMed ID: 28605488
[TBL] [Abstract][Full Text] [Related]
35. [Phenotypic and Genotypic Evaluation of Azole Resistance in Aspergillus fumigatus Isolates from Clinical and Environmental Specimens].
Doğan Ö; Gülmez D; Arıkan Akdağlı S
Mikrobiyol Bul; 2020 Apr; 54(2):291-305. PubMed ID: 32723284
[TBL] [Abstract][Full Text] [Related]
36. First detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment.
Astvad KM; Jensen RH; Hassan TM; Mathiasen EG; Thomsen GM; Pedersen UG; Christensen M; Hilberg O; Arendrup MC
Antimicrob Agents Chemother; 2014 Sep; 58(9):5096-101. PubMed ID: 24936595
[TBL] [Abstract][Full Text] [Related]
37. A Novel Combination of
Macedo D; Brito Devoto T; Pola S; Finquelievich JL; Cuestas ML; Garcia-Effron G
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32423948
[TBL] [Abstract][Full Text] [Related]
38. First azole-resistant Aspergillus fumigatus isolates with the environmental TR
Ahangarkani F; Puts Y; Nabili M; Khodavaisy S; Moazeni M; Salehi Z; Laal Kargar M; Badali H; Meis JF
Mycoses; 2020 May; 63(5):430-436. PubMed ID: 32056319
[TBL] [Abstract][Full Text] [Related]
39. cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.
Bader O; Weig M; Reichard U; Lugert R; Kuhns M; Christner M; Held J; Peter S; Schumacher U; Buchheidt D; Tintelnot K; Groß U;
Antimicrob Agents Chemother; 2013 Aug; 57(8):3513-7. PubMed ID: 23669382
[TBL] [Abstract][Full Text] [Related]
40. PCR-based detection of Aspergillus fumigatus and absence of azole resistance due to TR
Morio F; Dannaoui E; Chouaki T; Cateau E; Malard O; Bonfils P; Page C; Dufour X; Cottrel C; Erwan T; Lavergne RA; Le Pape P
Mycoses; 2018 Jan; 61(1):30-34. PubMed ID: 28922487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
